miRNA Regulation Network Analysis in Qianliening Capsule Treatment of Benign Prostatic Hyperplasia

Table 1

Differentially expressed miRNA between the BPH-1 cells treated with QC (2.5 mg/mL) group and control group.

miRNA	Fold change (QC versus CTR)
miR-3663-3p	5.25562
miR-4730	5.15551
miR-34c-5p	3.4525
miR-122	3.40821
miR-4674	3.30796
miR-34a	3.28902
miR-4734	3.19241
miR-3178	3.1713
miR-4497	3.164
miR-4649-5p	2.96402
miR-3185	2.96402
miR-3621	2.90446
miR-663	2.60666
miR-4634	2.55855
miR-4745-5p	2.31046
miR-34a	2.21767
miR-4665-5p	2.11388
miR-3195	2.06861
miR-1231	2.04573
miR-125b-1	−2.47347
miR-1972	−2.76246

Positive value indicated upregulation and negative value indicated downregulation. miRNA with expression fold change >2 and P value < 0.05 was considered statistically significant. QC: BPH-1 cells treated with QC (2.5 mg/mL); CTR: control group.